JTE-061 Cream
Pediatric Atopic Dermatitis
NDA FiledUnder Review (filed Oct 2025)
Key Facts
Indication
Pediatric Atopic Dermatitis
Phase
NDA Filed
Status
Under Review (filed Oct 2025)
Company
About Torii Pharmaceutical
Japanese dermatology-focused pharmaceutical company specializing in rare skin disease treatments through small molecule and topical formulations.
View full company profile